Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$7,400,506
-$876,551 QoQ
Shares Held
307,330
+4.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#491
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Mar 31, 2022CallValue
$5,177
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Moors & Cabot, Inc. holds $115,416,483 across 14 Drug Manufacturers - General names. PFE ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
120,434 | $30,586,622 | |
| 2 | LLY |
ELI LILLY & Co
|
22,840 | $27,394,983 | |
| 3 | ABBV |
AbbVie Inc.
|
70,717 | $17,795,225 | |
| 4 | MRK |
Merck & Co., Inc.
|
94,665 | $12,164,452 | |
| 5 | PFE |
Pfizer Inc
This page
|
307,330 | $7,400,506 | |
| 6 | AMGN |
Amgen Inc
|
14,884 | $5,389,794 | |
| 7 | NVS |
Novartis AG
|
28,770 | $4,508,834 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
62,967 | $3,628,158 |
All Filings in PFE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,400,506 | 307,330 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $8,277,057 | 294,767 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $7,032,332 | 282,423 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $10,057,669 | 394,728 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,970,930 | 411,342 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $9,977,726 | 393,754 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $10,676,467 | 402,430 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $12,551,827 | 433,719 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $12,624,072 | 451,182 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $10,547,775 | 380,100 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $6,955,894 | 241,608 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,376,751 | 252,540 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $12,349,679 | 336,687 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $13,963,351 | 342,239 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $17,471,815 | 340,980 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $14,949,641 | 341,628 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $18,179,997 | 346,748 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $17,989,350 | 347,486 | Shares | Sole | 2022-05-13 | |
| 2022-03-31 | $5,177 | 100 | Call | Sole | 2022-05-13 | |
| 2021-12-31 | $21,568,839 | 365,264 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $31,448,738 | 731,196 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $13,941,860 | 356,023 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $12,683,362 | 350,079 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $12,126,391 | 329,432 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $11,763,182 | 320,523 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $8,611,357 | 263,344 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,483,339 | 198,632 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||